German health funds' profits cheers minister:
This article was originally published in Clinica
Germany's statutory health insurance funds made profits of Euros2.4bn ($2.9bn) in the first half of 2004, against a deficit of almost Euros2bn for the same period last year. Health minister Ulla Schmidt said the turnaround showed that her health reform law is having the desired effect. Compared with the same period last year, expenditure on medical technical aids fell by Euros340m. This is in part due to the imposition of co-payments in this sector and expenditure is likely to fall further following legislation due soon that would allow funds to negotiate contracts and then reimburse products from only those manufacturers and distributors whose prices fall within the lowest third price bracket.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.